Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates
Impact BioMedical, Inc. (IBO)
Company Research
Source: GlobeNewswire
HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, is pleased to announce the successful completion of its Initial Public Offering (IPO). Notable is that over 30% of the IPO was purchased by existing investors which further demonstrates strong belief in the company and its potential. Frank D. Heuszel, CEO of Impact BioMedical, commented, "The significant participation of our investors underscores their confidence in our mission and the innovative healthcare solutions we are developing. Their support is a testament to the value they see in our work and our potential to make a meaningful impact on human health." About Impact BioMedical, Inc.: Impact BioMedical Inc. (NYSE American: IBO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in biopharmaceuticals and consumer he
Show less
Read more
Impact Snapshot
Event Time:
IBO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IBO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IBO alerts
High impacting Impact BioMedical, Inc. news events
Weekly update
A roundup of the hottest topics
IBO
News
- Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision [Yahoo! Finance]Yahoo! Finance
- Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic VisionGlobeNewswire
- Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory DiseaseGlobeNewswire
- Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent IssueGlobeNewswire
- Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and GrowthGlobeNewswire
IBO
Sec Filings
- 11/12/24 - Form 10-Q
- 9/19/24 - Form 4
- 9/18/24 - Form 4
- IBO's page on the SEC website